• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,25-二羟基维生素D通过DDIT4抑制高糖诱导的大鼠系膜细胞增殖。

1,25-Dihydroxyvitamin D inhibits the proliferation of rat mesangial cells induced by high glucose via DDIT4.

作者信息

Chen Da-Peng, Ma Ye-Ping, Zhuo Li, Zhang Zheng, Zou Gu-Ming, Yang Yue, Gao Hong-Mei, Li Wen-Ge

机构信息

Graduate School of Peking Union Medical College, Beijing 100730, China.

Department of Nephrology, China-Japan Friendship Hospital, Beijing 100029, China.

出版信息

Oncotarget. 2017 Dec 9;9(1):418-427. doi: 10.18632/oncotarget.23063. eCollection 2018 Jan 2.

DOI:10.18632/oncotarget.23063
PMID:29416624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787477/
Abstract

1,25-Dihydroxyvitamin D(1,25(OH) D) is a secosteroid with antiproliferative property. It also plays a pivotal renoprotective role in diabetic nephropathy. We investigated whether 1,25(OH)D could inhibit the proliferation of rat mesangial cells exposed to high glucose via the DNA-damage-inducible transcript 4/mammalian target of rapamycin(DDIT4/mTOR) pathway. The cell proliferation rate and cell cycle duration were measured using cell counting kit-8 assay and flow cytometry. Protein expression was assayed by Western blot. Glucose acted as a growth factor in rat mesangial cells, promoted cell proliferation. In parallel, the protein expression of DDIT4, TSC1/TSC2, and 4E-BP1 were decreased, and Rheb, mTOR, and p70S6K were increased. Acting via the DDIT4/mTOR signaling, 1,25(OH) D treatment reversed these pathological changes, upregulated DDIT4, TSC1/TSC2, and 4E-BP1, downregulated Rheb, mTOR, and p70S6K. The short-term overexpression of DDIT4 inhibited the proliferation of rat mesangial cells, similar to 1,25(OH) D treatment. siRNA knockdown of DDIT4 suppressed antiproliferative responses to 1,25(OH) D. These results suggest that 1,25(OH) D inhibits the proliferation of rat mesangial cells induced by high glucose via the DDIT4/mTOR signaling pathway.

摘要

1,25-二羟基维生素D(1,25(OH)D)是一种具有抗增殖特性的甾体类化合物。它在糖尿病肾病中也发挥着关键的肾脏保护作用。我们研究了1,25(OH)D是否能通过DNA损伤诱导转录本4/哺乳动物雷帕霉素靶蛋白(DDIT4/mTOR)途径抑制暴露于高糖环境下的大鼠系膜细胞的增殖。使用细胞计数试剂盒-8法和流式细胞术测量细胞增殖率和细胞周期持续时间。通过蛋白质印迹法检测蛋白质表达。葡萄糖在大鼠系膜细胞中充当生长因子,促进细胞增殖。同时,DDIT4、结节性硬化复合物1/2(TSC1/TSC2)和真核细胞起始因子4E结合蛋白1(4E-BP1)的蛋白质表达降低,而小G蛋白Rheb、mTOR和p70核糖体蛋白S6激酶(p70S6K)的表达增加。通过DDIT4/mTOR信号传导,1,25(OH)D处理逆转了这些病理变化,上调了DDIT4、TSC1/TSC2和4E-BP1,下调了Rheb、mTOR和p70S6K。DDIT4的短期过表达抑制了大鼠系膜细胞的增殖,类似于1,25(OH)D处理。DDIT4的小干扰RNA(siRNA)敲低抑制了对1,25(OH)D的抗增殖反应。这些结果表明,1,25(OH)D通过DDIT4/mTOR信号通路抑制高糖诱导的大鼠系膜细胞增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/99b5fc39767a/oncotarget-09-418-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/933b02a99cc2/oncotarget-09-418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/b5e2c813ef1a/oncotarget-09-418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/a9922f035cbb/oncotarget-09-418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/db13bd5c7bc7/oncotarget-09-418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/99b5fc39767a/oncotarget-09-418-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/933b02a99cc2/oncotarget-09-418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/b5e2c813ef1a/oncotarget-09-418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/a9922f035cbb/oncotarget-09-418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/db13bd5c7bc7/oncotarget-09-418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da59/5787477/99b5fc39767a/oncotarget-09-418-g005.jpg

相似文献

1
1,25-Dihydroxyvitamin D inhibits the proliferation of rat mesangial cells induced by high glucose via DDIT4.1,25-二羟基维生素D通过DDIT4抑制高糖诱导的大鼠系膜细胞增殖。
Oncotarget. 2017 Dec 9;9(1):418-427. doi: 10.18632/oncotarget.23063. eCollection 2018 Jan 2.
2
In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.1,25-二羟基维生素D通过DDIT4/TSC2/mTOR途径在体外和体内抑制mTOR以改善早期糖尿病肾病。
Endocrine. 2016 Nov;54(2):348-359. doi: 10.1007/s12020-016-0999-1. Epub 2016 Jul 9.
3
1, 25(OH)2D3 protects β cell against high glucose-induced apoptosis through mTOR suppressing.1,25-二羟维生素D3通过抑制mTOR保护β细胞免受高糖诱导的凋亡。
Mol Cell Endocrinol. 2015 Oct 15;414:111-9. doi: 10.1016/j.mce.2015.07.023. Epub 2015 Jul 26.
4
DNA damage-inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti-carcinoma effect of 1,25(OH) D.DNA 损伤诱导转录物 4 是人类鳞状细胞癌的先天守护者,也是 1,25(OH)D 抗癌作用的分子载体。
Exp Dermatol. 2019 Jan;28(1):45-52. doi: 10.1111/exd.13815. Epub 2018 Dec 5.
5
Alpha Lipoic Acid Modulated High Glucose-Induced Rat Mesangial Cell Dysfunction via mTOR/p70S6K/4E-BP1 Pathway.α-硫辛酸通过mTOR/p70S6K/4E-BP1信号通路调节高糖诱导的大鼠系膜细胞功能障碍
Int J Endocrinol. 2014;2014:658589. doi: 10.1155/2014/658589. Epub 2014 Oct 30.
6
DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes.DNA损伤诱导转录物4(DDIT4)通过心肌细胞中的mTOR信号通路介导甲基苯丙胺诱导的自噬和凋亡。
Toxicol Appl Pharmacol. 2016 Mar 15;295:1-11. doi: 10.1016/j.taap.2016.01.017. Epub 2016 Jan 26.
7
Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease.解析维生素D受体-雷帕霉素靶蛋白通路中的DDIT4:糖尿病肾病药物研发的新靶点
Front Pharmacol. 2024 Mar 19;15:1344113. doi: 10.3389/fphar.2024.1344113. eCollection 2024.
8
High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling.高糖诱导的系膜细胞肥大可通过间隙连接蛋白 43 过表达通过 PTEN/Akt/mTOR 信号通路逆转。
Nephrol Dial Transplant. 2012 Jan;27(1):90-100. doi: 10.1093/ndt/gfr265. Epub 2011 Jun 1.
9
1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells.1,25-二羟基维生素D3作用于核因子κB可抑制高糖诱导的系膜细胞单核细胞趋化蛋白-1表达。
Kidney Int. 2007 Jul;72(2):193-201. doi: 10.1038/sj.ki.5002296. Epub 2007 May 16.
10
1α,25-Dihydroxyvitamin D3 upregulates HIF-1 and TREM-1 via mTOR signaling.1α,25-二羟基维生素D3通过mTOR信号通路上调缺氧诱导因子-1(HIF-1)和触发受体表达分子-1(TREM-1)
Immunol Lett. 2015 Jan;163(1):14-21. doi: 10.1016/j.imlet.2014.11.004. Epub 2014 Nov 15.

引用本文的文献

1
Exploring the protective role of DDIT4/mTOR in podocyte integrity through macrophage polarization in diabetic kidney disease.通过巨噬细胞极化探讨DDIT4/mTOR在糖尿病肾病足细胞完整性中的保护作用。
Ren Fail. 2025 Dec;47(1):2546623. doi: 10.1080/0886022X.2025.2546623. Epub 2025 Sep 7.
2
mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets.mTOR信号通路:糖尿病肾病进展中的关键因素及治疗靶点。
Genes Dis. 2024 Mar 8;12(2):101260. doi: 10.1016/j.gendis.2024.101260. eCollection 2025 Mar.
3
Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease.

本文引用的文献

1
In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.1,25-二羟基维生素D通过DDIT4/TSC2/mTOR途径在体外和体内抑制mTOR以改善早期糖尿病肾病。
Endocrine. 2016 Nov;54(2):348-359. doi: 10.1007/s12020-016-0999-1. Epub 2016 Jul 9.
2
Vitamin D deficiency and related risk factors in patients with diabetic nephropathy.糖尿病肾病患者的维生素D缺乏及相关危险因素
J Int Med Res. 2016 Jun;44(3):673-84. doi: 10.1177/0300060515593765. Epub 2016 Mar 4.
3
siRNA Versus miRNA as Therapeutics for Gene Silencing.
解析维生素D受体-雷帕霉素靶蛋白通路中的DDIT4:糖尿病肾病药物研发的新靶点
Front Pharmacol. 2024 Mar 19;15:1344113. doi: 10.3389/fphar.2024.1344113. eCollection 2024.
4
Resveratrol improves palmitic acid‑induced insulin resistance via the DDIT4/mTOR pathway in C2C12 cells.白藜芦醇通过 DDIT4/mTOR 通路改善棕榈酸诱导的 C2C12 细胞胰岛素抵抗。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13068. Epub 2023 Aug 18.
5
Circulating levels of DDIT4 and mTOR, and contributions of BMI, inflammation and insulin sensitivity in hyperlipidemia.高脂血症中DDIT4和mTOR的循环水平以及体重指数、炎症和胰岛素敏感性的作用。
Exp Ther Med. 2022 Sep 8;24(5):666. doi: 10.3892/etm.2022.11602. eCollection 2022 Nov.
6
Causal Links between Hypovitaminosis D and Dysregulation of the T Cell Connection of Immunity Associated with Obesity and Concomitant Pathologies.维生素D缺乏与肥胖及相关合并症所伴免疫T细胞连接失调之间的因果联系
Biomedicines. 2021 Nov 23;9(12):1750. doi: 10.3390/biomedicines9121750.
作为基因沉默疗法的小干扰RNA与微小RNA
Mol Ther Nucleic Acids. 2015 Sep 15;4(9):e252. doi: 10.1038/mtna.2015.23.
4
1, 25(OH)2D3 protects β cell against high glucose-induced apoptosis through mTOR suppressing.1,25-二羟维生素D3通过抑制mTOR保护β细胞免受高糖诱导的凋亡。
Mol Cell Endocrinol. 2015 Oct 15;414:111-9. doi: 10.1016/j.mce.2015.07.023. Epub 2015 Jul 26.
5
The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus.2型糖尿病微血管并发症与维生素D缺乏之间的关系。
BMC Endocr Disord. 2015 Jun 25;15:33. doi: 10.1186/s12902-015-0029-y.
6
Inhibition of RAS in diabetic nephropathy.糖尿病肾病中RAS的抑制作用。
Int J Nephrol Renovasc Dis. 2015 Apr 15;8:29-40. doi: 10.2147/IJNRD.S37893. eCollection 2015.
7
Reciprocal regulation of cilia and autophagy via the MTOR and proteasome pathways.通过MTOR和蛋白酶体途径对纤毛和自噬进行相互调节。
Autophagy. 2015 Apr 3;11(4):607-16. doi: 10.1080/15548627.2015.1023983.
8
The SCL/TAL1 Transcription Factor Represses the Stress Protein DDiT4/REDD1 in Human Hematopoietic Stem/Progenitor Cells.SCL/TAL1 转录因子抑制人造血干/祖细胞中的应激蛋白 DDiT4/REDD1。
Stem Cells. 2015 Jul;33(7):2268-79. doi: 10.1002/stem.2028. Epub 2015 May 25.
9
Diabetic kidney disease: a report from an ADA Consensus Conference.糖尿病肾病:ADA 共识会议报告。
Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.
10
Vitamin D inhibition of lung adenocarcinoma cell proliferation in vitro.维生素D对肺腺癌细胞体外增殖的抑制作用。
Tumour Biol. 2014 Nov;35(11):10953-8. doi: 10.1007/s13277-014-1994-x. Epub 2014 Aug 3.